Literature DB >> 2999540

Neuropeptide Y (NPY) binding sites in rat brain labeled with 125I-Bolton-Hunter NPY: comparative potencies of various polypeptides on brain NPY binding and biological responses in the rat vas deferens.

R S Chang, V J Lotti, T B Chen, D J Cerino, P J Kling.   

Abstract

The binding of biologically active 125I-Bolton-Hunter (BH)-NPY to rat brain membranes was saturable and reversible and regulated by inorganic cations and guanyl nucleotides consistent with other neurotransmitter receptor systems. The concentration of specific 125I-NPY binding differed in various brain regions, being highest in the hippocampus and lowest in the cerebellum. Scatchard analysis of 125I-NPY binding showed a single class of receptor sites with a Kd = 0.1 nM and Bmax of 3 pmole/g tissue in hippocampus. Peptide YY, porcine and human NPY inhibited the specific 125I-BH-NPY binding with IC50 values of 50-120 pM. In contrast, human NPY free acid and pancreatic polypeptides from human (HPP), rat (RPP) and avian (APP) sources were much weaker (IC50 greater than or equal to 300 nM). The rank order of potencies for NPY analogs and the inactivity of APP and HPP fragment (31-36) on brain binding appeared to correlate with their relative activities in inhibiting contractions of the field-stimulated rat vas deferens. However, PYY, HPP and RPP exhibited activity in the field-stimulated rat vas deferens indicative of a possible action upon sites distinct from the brain NPY binding site.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999540     DOI: 10.1016/0024-3205(85)90583-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

Review 1.  The role of neuropeptides in cardiovascular regulation.

Authors:  D Ganten; M Paul; R E Lang
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

2.  Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.

Authors:  R S Chang; V J Lotti
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

3.  Centrally truncated and stabilized porcine neuropeptide Y analogs: design, synthesis, and mouse brain receptor binding.

Authors:  J L Krstenansky; T J Owen; S H Buck; K A Hagaman; L R McLean
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

4.  Structure activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C-terminal NPY analogues.

Authors:  L J Cross; A G Beck-Sickinger; M Bienert; W Gaida; G Jung; E Krause; M Ennis
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

5.  The actions of the peptides, neuropeptide Y and peptide YY, on the vascular and capsular smooth muscle of the isolated, blood-perfused spleen of the dog.

Authors:  R Corder; P J Lowry; P G Withrington
Journal:  Br J Pharmacol       Date:  1987-04       Impact factor: 8.739

6.  Neuropeptide Y acylation chemistry in aqueous solution: significance to synthesis of a peptide-based photoaffinity label.

Authors:  L Hu; M B Doughty
Journal:  J Protein Chem       Date:  1994-01

7.  Colocalization of neuropeptide Y (NPY)-like and FMRFamide-like immunoreactivities in the brain of the Atlantic salmon (Salmo salar).

Authors:  E Vecino; P Ekström
Journal:  Cell Tissue Res       Date:  1992-12       Impact factor: 5.249

8.  Neuropeptide Y: a powerful modulator of epithelial ion transport.

Authors:  D D Friel; R J Miller; M W Walker
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

9.  Neuropeptide Y (NPY) and peptide YY (PYY) receptors in rat brain.

Authors:  T Ohkubo; M Niwa; K Yamashita; Y Kataoka; K Shigematsu
Journal:  Cell Mol Neurobiol       Date:  1990-12       Impact factor: 5.046

10.  Neuropeptide Y reduces expression of social fear via simultaneous activation of Y1 and Y2 receptors.

Authors:  Johannes Kornhuber; Iulia Zoicas
Journal:  J Psychopharmacol       Date:  2019-07-22       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.